Ko T M, Hwa H L, Liu C W, Li S F, Chu J Y, Cheung Y P
Department of Obstetrics and Gynecology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Ann Hematol. 1999 Aug;78(8):355-7. doi: 10.1007/s002770050528.
In order to determine the prevalence and molecular basis of alpha-thalassemia (thal) among Filipinos, a total of 2954 Filipinos in Taiwan were enrolled in this study. A complete blood count was done for every subject. Those with microcytosis (MCV less than 82.5 fl) were studied with hemoglobin (Hb) high-performance liquid chromatography to determine the levels of Hb A2 and Hb F, and with an enzyme immunoassay to determine plasma ferritin levels. Those who had microcytosis and normal or low levels of Hb A2 and Hb F were further studied with molecular methods for alpha-globin gene mutations. We used Southern blot hybridization and/or the polymerase chain reaction to detect Southeast Asian deletion, Filipino deletion, rightward and leftward single alpha-globin gene deletions, and Hb Constant Spring and Hb Quong Sze. Specific amplification and direct DNA sequencing of the alpha2- and alpha1-globin genes were carried out in apparent alpha-thal carriers without any of the above-mentioned mutations. Our results showed that in Filipinos the prevalence of alpha-thal 1 was 5% (147 carriers) and that of alpha-thal 2 was 1.7% (49 carriers); two had Hb H disease. Among the alpha-thal 1 carriers, 89 had the Southeast Asian deletion and 58 had the Filipino deletion. Among the alpha-thal 2 carriers, 48 had a rightward deletion and one had a leftward deletion. None had Hb Constant Spring or Hb Quong Sze. Specific amplification and DNA sequencing in five apparent alpha-thal carriers did not reveal mutations in the 2-kb region spanning the alpha2- and alpha1-globin genes. The molecular defects of alpha-thal in Filipinos were different from those in the neighboring ethnic groups. Elucidation of the alpha-thal mutations in Filipinos is useful in the genetic counseling and prenatal diagnosis of this common disease.
为了确定菲律宾人中α地中海贫血(地贫)的患病率及分子基础,本研究纳入了2954名在台湾的菲律宾人。对每位受试者进行了全血细胞计数。对那些有小红细胞症(平均红细胞体积小于82.5飞升)的人,采用血红蛋白高效液相色谱法测定血红蛋白A2和血红蛋白F水平,并采用酶免疫测定法测定血浆铁蛋白水平。对那些有小红细胞症且血红蛋白A2和血红蛋白F水平正常或降低的人,进一步采用分子方法研究α珠蛋白基因突变。我们使用Southern印迹杂交和/或聚合酶链反应检测东南亚缺失型、菲律宾缺失型、向右和向左的单个α珠蛋白基因缺失,以及血红蛋白Constant Spring和血红蛋白Quong Sze。对未出现上述任何突变的明显α地贫携带者进行α2和α1珠蛋白基因的特异性扩增和直接DNA测序。我们的结果显示,在菲律宾人中,α地贫1的患病率为5%(147名携带者),α地贫2的患病率为1.7%(49名携带者);2人患有血红蛋白H病。在α地贫1携带者中,89人有东南亚缺失型,58人有菲律宾缺失型。在α地贫2携带者中,48人有向右缺失型,1人有向左缺失型。无人有血红蛋白Constant Spring或血红蛋白Quong Sze。对5名明显的α地贫携带者进行特异性扩增和DNA测序,未发现跨越α2和α1珠蛋白基因的2千碱基区域存在突变。菲律宾人中α地贫的分子缺陷与邻近族群不同。阐明菲律宾人中的α地贫突变对这种常见疾病的遗传咨询和产前诊断很有用。